Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)

NCT00500656 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

DRUG: Icatibant
DRUG: Tranexamic Acid
DRUG: Oral Placebo
DRUG: S.C. Placebo

Sponsor

Shire